Literature DB >> 836537

Somatostatin in human cerebrospinal fluid.

Y Patel, K Rao, S Reichlin.   

Abstract

To determine whether somatostatin is found in the hypothalamus and extrahypothalamic brain, we studied autopsy brain tissue by specific immunoassay. The hypothalamus contained the highest concentration (16.7 +/- 2.4 S.D. pg per microgram of protein), with small amounts in brainstem, cerebral cortex, cerebellum, pineal gland and spinal cord. Cerebrospinal fluid of seven neurologically normal persons also contained somatostatin in concentrations ranging from 15 to 55 pg per milliliter. To determine whether brain disease leads to abnormal cerebrospinal-fluid somatostatin, we examined 30 patients with neurologic disease, of whom 20 of 24 with cord or cerebral disease had concentrations above the highest normal level. The wide variety of diseases with somatostatin elevation suggests nonspecific leakage from damaged brain tissue. Cerebrospinal-fluid somatostatin may provide a good index of brain damage. Although correlated statistically with cerebrospinal-fluid protein, somatostatin concentration in five of 24 cases exceeded the upper limit of normal by 3 S.D. while protein was normal.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836537     DOI: 10.1056/NEJM197703102961002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

2.  Immunohistochemical and cytochemical localization of the somatostatin receptor subtype sst1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus.

Authors:  L Helboe; C E Stidsen; M Moller
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

3.  Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome.

Authors:  W C Parris; J A Oates; J Kambam; R Shmerling; J F Sawyers
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

4.  Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors:  E E Müller
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

5.  Huntington's chorea-- measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.

Authors:  H Cramer; J Kohler; G Oepen; G Schomburg; E Schröter
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

6.  Distribution of immunoreactive somatostatin in the primate hypothalamus.

Authors:  A B Filby; D S Gross
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

7.  Postmortem stability of somatostatin-like immunoreactivity in mouse brain under conditions simulating handling of human autopsy material.

Authors:  P Davies; A Thompson
Journal:  Neurochem Res       Date:  1981-07       Impact factor: 3.996

8.  Neurohormones in the intercellular clefts and in glia-like cells of the rat brain.

Authors:  B Krisch; H Leonhardt
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

9.  Differential somatostatin receptor subtype expression in human normal pineal gland and pineal parenchymal tumors.

Authors:  J Champier; A Jouvet; C Rey; J Guyotat; M Fevre-Montange
Journal:  Cell Mol Neurobiol       Date:  2003-02       Impact factor: 5.046

10.  Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients.

Authors:  J Kohler; E Schröter; H Cramer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.